Institute for Applied Cancer Science
Meet the Team
Currently seventy scientists, most recruited from leading biotechnology and pharmaceutical companies, drive programs in metabolism, epigenetics, and signaling toward the goal of developing novel therapies for patients and an understanding of how these might be used clinically. Collectively, IACS team members have several hundred years of industry experience, as well as proven track records of effectively translating targets into clinically significant treatments that are in late stage clinical trials, plus one FDA approved agent.
To effectively move a program forward multiple disciplines work together in a seamless manner to make a program successful. Merging scientific cultures into cross-functional teams that integrate multiple specialized scientific disciplines leads to increased productivity and innovation. Project teams are nimble and accountable driving projects from hypothesis through proof-of-concept to development.
Cross-functional Teams Cooperate
to Advance IACS Programs